Astronaut loading animation Circular loading bar

Try : Insurtech, Application Development

AgriTech(1)

Augmented Reality(20)

Clean Tech(5)

Customer Journey(12)

Design(35)

Solar Industry(6)

User Experience(55)

Edtech(10)

Events(34)

HR Tech(2)

Interviews(10)

Life@mantra(11)

Logistics(5)

Strategy(17)

Testing(9)

Android(47)

Backend(30)

Dev Ops(7)

Enterprise Solution(27)

Technology Modernization(2)

Frontend(28)

iOS(43)

Javascript(15)

AI in Insurance(35)

Insurtech(63)

Product Innovation(49)

Solutions(19)

E-health(10)

HealthTech(22)

mHealth(5)

Telehealth Care(4)

Telemedicine(5)

Artificial Intelligence(132)

Bitcoin(8)

Blockchain(19)

Cognitive Computing(7)

Computer Vision(8)

Data Science(17)

FinTech(50)

Banking(7)

Intelligent Automation(26)

Machine Learning(47)

Natural Language Processing(14)

expand Menu Filters

Android N Developer Preview 4

Android N Developer Preview 4 has been recently released. According to the Google, Developer Preview 4 includes the final APIs, which is API level 24. That means apps can now be published with support for API level 24 on Google Play in alpha, beta, and production release channels. Google is also providing the final API to Android Studio 2.1.2 and higher, while also pushing system images to the emulator.Android-N-notifications(1)

New in Developer’s Preview 4

Android N final APIs

Developer Preview 4 includes the final APIs for the upcoming Android N platform. The new API level is 24.

Play publishing

You can now publish apps that use API level 24 to Google Play, in alpha, beta, and production release channels.

Android Studio and tools updates

Along with Developer Preview 4 Google is providing the final API 24 SDK to be used with Android Studio 2.1.2 and higher. In addition, Google is releasing updated Developer Preview 4 system images for the emulator to help test your apps.

As new updates roll out for Android Studio, you should see minor improvements in the new project wizards and AVD manager as we add enhanced support for API 24. These are primarily cosmetic changes and should not stop you from getting your app ready for an update in the Play store.

Here are some of the new feature changes:

  • In previous versions of Android, an app activates with all of its locale resources loaded before locale negotiation begins. Starting in Android N DP4, the system negotiates resource locales individually for each resource object before the app activates.
  • As announced at Developer Preview 3, Google deferred the Launcher Shortcuts feature to a later release of Android. In Developer Preview 4, Google removed the Launcher Shortcuts APIs.
  • Google has changed the BLE Scanning behavior starting in DP4. They have prevented applications from starting and stopping scans more than 5 times in 30 seconds. For long running scans, google will convert them into opportunistic scans.
  • The Multi-Window android:minimalHeight and android:minimalWidth attributes have been renamed to android:minHeight and android:minWidth.gsmarena_000(1)

Known Issues:

  • Stability – Users may encounter system instability (such as kernel panics and crashes).
  • Launcher – The default launcher’s All Apps tray may become unresponsive after cycling the screen off and on. Returning to the homescreen and relaunching the All Apps tray may resolve this issue.
  • Setup Wizard – Crash on selecting “Not now” in “Set up email” screen.
  • Media – Media playback may be unreliable on Nexus 9 and Nexus Player, including issues playing HD video.
    -Occasional freeze when running the YouTube app with other apps in multi-window mode on Pixel C devices. In some cases hard reboot is required.
    -Apps may have issues playing some Widevine DRM-protected content on Nexus 9 devices.
    -Issues handling VP8 video on Nexus 9 devices.
  • External storage – Apps may become unstable when the user moves them from internal storage to adoptable external storage (this can include SD card or devices attached over USB).
  • Screen zoom and multiple APKs in Google Play – On devices running Android N, Google Play services 9.0.83 incorrectly reports the current screen density rather than the stable screen density. When screen zoom is enabled on these devices, this can cause Google Play to select a version of a multi-APK app that’s designed for smaller screens. This issue is fixed in the next version of Google Play services and will be included in a later Developer Preview release.
  • Vulkan support and multiple APKs in Google Play – On devices running Android N, Google Play services 9.0.83 currently reports Vulkan support but not Vulkan version. This can cause Google Play to select a version of a multi-APK app that’s designed for lower Vulkan support on devices with higher version support. Currently, the Google Play Store does not accept uploads of apps which use Vulkan version targeting. This support will be added to the Google Play Store in the future and fixed in the next version of Google Play services (to be included in a later Developer Preview release). Any N devices using the version of Google Play services 9.0.83 will continue to receive versions of apps targeting basic Vulkan support.
  • Accessibility – Switch access doesn’t allow user to navigate web pages in Chrome.
    -Accessibility issues for talkback users with notification dismissal, and wifi selection screen.
  • Android for Work – Currently, CA certificates provisioned through DevicePolicyManager are not available to profiles other than the primary user/profile due to a preload issue. For example, this could prevent a user from connecting to a trusted server when in a Work profile. This issue will be resolved in the next Developer Preview.

 

If you’re a developer and would like to make sure your updated application runs well on Android N, you’ll want to look into using Google Play’s beta testing feature.

Coming in a build number NPD56N, factory images are now available for the Nexus 6P, Nexus 5X, Nexus 6, Nexus 9, Pixel C, Nexus Player, General Mobile 4G (Android One) and the Sony Xperia Z3. Full OTA images are also available, but not for the Z3. If you aren’t keen on updating manually, you can always enroll your device in the Android Beta Program.

For a complete overview of what’s new for users and developers, Approach Mantra Labs at hello@mantralabsglobal.com

Cancel

Knowledge thats worth delivered in your inbox

Embracing the Digital Frontier: Transforming the Patient Journey in Pharma

In the realm of pharmaceuticals, the digital revolution is not just a buzzword; it’s a seismic shift reshaping the landscape of patient care. From discovery to delivery, digital technologies are revolutionizing every facet of the pharmaceutical industry. One of the most profound impacts is evident in the patient journey. Today’s Patients are more informed, engaged, and empowered than ever, thanks to the proliferation of digital tools and platforms. In this comprehensive exploration, we will delve into the multifaceted ways digital is redefining the patient journey in pharmaceuticals.

According to a report by Accenture on the rise of digital health, these are the key challenges to overcome:

  • 99% of respondents indicated that the development and commercialization of Digital Health solutions has accelerated in the past two years. As part of this, companies require various new and strengthened capabilities to execute their visions. 
  • Patients and health professionals need to trust that the data collected is accurate, safe, and secure for them to feel comfortable using it. 
  • Fragmented data or lack of access to data has been a barrier to development. An overarching guideline on data privacy is needed.

Leveraging Digital Solutions for Accessible Drug Delivery

In the pharmaceutical industry, the journey of medication from production facilities to patients’ hands is evolving with the integration of digital solutions. These technologies not only streamline logistics but also ensure that medications reach even the most remote and underserved areas. Let’s delve into how digital innovations are transforming drug delivery and backend channels in the pharmaceutical industry.

Digital Backend Channels and Supply Chain Management:

Pharmaceutical firms leverage digital tech for efficient backend operations. Software like SAP Integrated Business Planning and Oracle SCM Cloud enable real-time tracking, inventory management, and demand forecasting. With AI and analytics, companies adapt to market changes swiftly, ensuring timely medication delivery and optimized supply chain logistics.

Innovative Digital Drug Delivery Technologies:

  1. Controlled Monitoring Systems: Digital temperature monitoring systems provide digital temperature monitoring solutions using IoT sensors and cloud platforms, safeguarding temperature-sensitive medications during transit, ensuring compliance with regulatory standards, and minimizing product spoilage risk.
  1. Last-Mile Delivery Platforms: Zipline and Nimblr.ai, along with LogiNext, employ digital last-mile delivery solutions, using drones and AI-powered logistics to transport vital medical supplies efficiently to remote regions, improving accessibility for underserved communities.
  1. Telemedicine Integration with Prescription: Integrated telemedicine and prescription platforms, like Connect2Clinic, are rapidly growing in response to COVID-19. With telehealth claims at 38 times pre-pandemic levels, the industry is projected to hit $82 billion by 2028, with a 16.5% annual growth rate. Mantra Labs partnered with Connect2Clinic, enabling seamless coordination between healthcare providers, pharmacies, and patients. This facilitates virtual consultations and electronic prescribing, benefiting remote patients with medical advice and prescriptions without in-person visits. These platforms enhance healthcare access, medication adherence, and patient engagement through personalized care plans and reminders.
  1. Community Health Worker Apps: CommCare and mHealth empower community health workers with digital tools for medication distribution, education, and patient monitoring. Customizable modules enable tracking inventories, health assessments, and targeted interventions, extending pharmaceutical reach to remote communities, and ensuring essential medications reach those in need.

Through the strategic deployment of digital solutions in drug delivery and backend channels, pharmaceutical companies are overcoming barriers to access and revolutionizing healthcare delivery worldwide. By embracing innovation and collaboration, they are not only improving patient outcomes but also advancing toward a more equitable and inclusive healthcare system.

Personalized Medicine:

Wearable devices and mobile apps enable personalized medicine by collecting real-time health data and tailoring treatment plans to individual needs. For example, fitness trackers monitor activity and vital signs, customizing exercise and medication. Personalized medicine optimizes efficacy, minimizes adverse effects, and enhances patient satisfaction by leveraging patient-specific data.

Enhanced Patient Engagement:

Pharmaceutical firms utilize digital platforms for patient engagement, fostering support and education during treatment. Through social media, mobile apps, and online communities, patients connect, access resources, and receive professional support. Two-way communication enhances collaboration and decision-making, boosting treatment adherence, health outcomes, and consumer loyalty. Click here to know more.

Data-Driven Insights:

The abundance of healthcare data offers pharma companies unique opportunities to understand patient behavior and treatment patterns. By leveraging big data analytics and artificial intelligence, they extract actionable insights from various sources like electronic health records and clinical trials. These insights inform targeted marketing, product development, and patient support programs. However, ensuring data privacy and security is crucial, requiring robust regulatory frameworks and transparent practices in the digital era.

Challenges and Considerations:

Maximizing the benefits of digital technologies requires addressing challenges like patient data privacy and equitable access to healthcare tech. Stringent safeguards are needed to protect confidentiality and trust, alongside efforts to bridge the digital divide. Regulatory frameworks must evolve to balance innovation with patient safety and security amidst rapid advancements in digital health.

Key Considerations for Pharma Companies in Embracing Digital Innovation:

  • Prioritize patient-centricity in digital initiatives, focusing on improving patient outcomes and experiences.
  • Invest in robust data privacy and security measures to build and maintain patient trust.
  • Foster collaboration and partnerships with technology companies and healthcare providers to drive innovation and scalability.
  • Leverage analytics and AI to derive actionable insights from healthcare data and inform decision-making processes.
  • Continuously monitor and adapt to regulatory requirements and industry standards to ensure compliance and mitigate risks.

Conclusion:

The digital revolution is not just a paradigm shift but a catalyst for transformation across the pharmaceutical industry. By embracing digital technologies, pharma companies can unlock new opportunities to enhance the patient journey, improve treatment outcomes, and drive sustainable growth. However, realizing the full potential of digital health requires collaboration, innovation, and a steadfast commitment to addressing the challenges and considerations inherent in this transformative journey. As we navigate the digital frontier, the future of patient care promises to be more connected, personalized, and empowering than ever before.

Cancel

Knowledge thats worth delivered in your inbox

Loading More Posts ...
Go Top
ml floating chatbot